Roberts, Glore & Co’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $729K | Buy |
6,059
+1,297
| +27% | +$150K | 0.2% | 106 |
|
|
2025
Q4 | $501K | Sell |
4,762
-153
| -3% | -$14.4K | 0.13% | 131 |
|
|
2025
Q3 | $413K | Sell |
4,915
-570
| -10% | -$46.9K | 0.11% | 149 |
|
|
2025
Q2 | $434K | Buy |
5,485
+780
| +17% | +$62K | 0.13% | 140 |
|
|
2025
Q1 | $422K | Buy |
4,705
+500
| +12% | +$46.7K | 0.13% | 132 |
|
|
2024
Q4 | $418K | Sell |
4,205
-1,000
| -19% | -$103K | 0.12% | 134 |
|
|
2024
Q3 | $591K | Hold |
5,205
| – | – | 0.17% | 114 |
|
|
2024
Q2 | $644K | Sell |
5,205
-144
| -3% | -$18.5K | 0.19% | 103 |
|
|
2024
Q1 | $706K | Hold |
5,349
| – | – | 0.21% | 101 |
|
|
2023
Q4 | $583K | Sell |
5,349
-112
| -2% | -$11.6K | 0.18% | 109 |
|
|
2023
Q3 | $562K | Sell |
5,461
-85
| -2% | -$9.16K | 0.19% | 105 |
|
|
2023
Q2 | $640K | Hold |
5,546
| – | – | 0.2% | 102 |
|
|
2023
Q1 | $590K | Buy |
5,546
+115
| +2% | +$12.4K | 0.2% | 106 |
|
|
2022
Q4 | $603K | Buy |
5,431
+216
| +4% | +$22.1K | 0.21% | 102 |
|
|
2022
Q3 | $449K | Hold |
5,215
| – | – | 0.16% | 116 |
|
|
2022
Q2 | $475K | Buy |
5,215
+133
| +3% | +$11.8K | 0.16% | 120 |
|
|
2022
Q1 | $417K | Hold |
5,082
| – | – | 0.12% | 139 |
|
|
2021
Q4 | $389K | Buy |
5,082
+12
| +0.2% | +$956 | 0.1% | 145 |
|
|
2021
Q3 | $381K | Buy |
5,070
+50
| +1% | +$3.8K | 0.12% | 139 |
|
|
2021
Q2 | $390K | Buy |
5,020
+189
| +4% | +$14.1K | 0.12% | 135 |
|
|
2021
Q1 | $355K | Sell |
4,831
-1,041
| -18% | -$76.8K | 0.11% | 139 |
|
|
2020
Q4 | $458K | Sell |
5,872
-52
| -0.9% | -$3.98K | 0.15% | 123 |
|
|
2020
Q3 | $468K | Hold |
5,924
| – | – | 0.17% | 115 |
|
|
2020
Q2 | $437K | Sell |
5,924
-3,609
| -38% | -$272K | 0.17% | 113 |
|
|
2020
Q1 | $699K | Sell |
9,533
-314
| -3% | -$24.7K | 0.3% | 79 |
|
|
2019
Q4 | $854K | Buy |
9,847
+5,569
| +130% | +$457K | 0.33% | 78 |
|
|
2019
Q3 | $344K | Hold |
4,278
| – | – | 0.21% | 105 |
|
|
2019
Q2 | $342K | Hold |
4,278
| – | – | 0.21% | 108 |
|
|
2019
Q1 | $339K | Sell |
4,278
-819
| -16% | -$61.3K | 0.21% | 106 |
|
|
2018
Q4 | $372K | Sell |
5,097
-472
| -8% | -$33.3K | 0.26% | 91 |
|
|
2018
Q3 | $377K | Hold |
5,569
| – | – | 0.22% | 105 |
|
|
2018
Q2 | $323K | Hold |
5,569
| – | – | 0.2% | 116 |
|
|
2018
Q1 | $289K | Buy |
5,569
+207
| +4% | +$11.2K | 0.18% | 116 |
|
|
2017
Q4 | $288K | Buy |
5,362
+336
| +7% | +$18.6K | 0.18% | 119 |
|
|
2017
Q3 | $307K | Sell |
5,026
-182
| -3% | -$11K | 0.2% | 111 |
|
|
2017
Q2 | $318K | Buy |
5,208
+182
| +4% | +$11.1K | 0.21% | 107 |
|
|
2017
Q1 | $305K | Sell |
5,026
-979
| -16% | -$59.4K | 0.21% | 108 |
|
|
2016
Q4 | $337K | Hold |
6,005
| – | – | 0.24% | 101 |
|
|
2016
Q3 | $358K | Buy |
6,005
+52
| +0.9% | +$3.04K | 0.26% | 95 |
|
|
2016
Q2 | $327K | Hold |
5,953
| – | – | 0.25% | 96 |
|
|
2016
Q1 | $301K | Buy |
5,953
+5
| +0.1% | +$245 | 0.23% | 105 |
|
|
2015
Q4 | $300K | Hold |
5,948
| – | – | 0.23% | 103 |
|
|
2015
Q3 | $280K | Hold |
5,948
| – | – | 0.22% | 107 |
|
|
2015
Q2 | $323K | Sell |
5,948
-393
| -6% | -$22K | 0.23% | 107 |
|
|
2015
Q1 | $348K | Sell |
6,341
-184
| -3% | -$10.4K | 0.24% | 98 |
|
|
2014
Q4 | $354K | Hold |
6,525
| – | – | 0.24% | 100 |
|
|
2014
Q3 | $369K | Sell |
6,525
-524
| -7% | -$29.4K | 0.26% | 96 |
|
|
2014
Q2 | $389K | Sell |
7,049
-271
| -4% | -$14.8K | 0.26% | 91 |
|
|
2014
Q1 | $397K | Sell |
7,320
-472
| -6% | -$24.4K | 0.27% | 93 |
|
|
2013
Q4 | $372K | Sell |
7,792
-925
| -11% | -$42.3K | 0.26% | 93 |
|
|
2013
Q3 | $396K | Sell |
8,717
-1,367
| -14% | -$62.4K | 0.29% | 86 |
|
|
2013
Q2 | $447K | Buy |
+10,084
| New | +$450K | 0.28% | 87 |
|
Other funds holding MRK
VCM
VPM
Roberts, Glore & Co's MRK Position: Q1 2026 in Review
Roberts, Glore & Co increased its Merck (MRK) stake by 27% in Q1 2026, buying an estimated $150K and bringing the position to 6,059 shares worth $729K. The position accounts for 0.2% of the portfolio, ranked #106.
Roberts, Glore & Co first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $854K in Q4 2019. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Roberts, Glore & Co held 6,059 shares of Merck worth $729K as of Q1 2026.
- Roberts, Glore & Co bought 1,297 Merck shares in Q1 2026, an estimated $150K.
- Merck made up 0.2% of Roberts, Glore & Co's portfolio in Q1 2026, its #106 holding.
- Roberts, Glore & Co first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
- Roberts, Glore & Co's Merck position peaked at $854K in Q4 2019.
- 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Roberts, Glore & Co's 13F filing for Q1 2026, filed 4 May 2026.